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To the Editor
In a classic 1970 publication, the 
famous epidemiologist Alvan R. 
Feinstein defined comorbidity in rela-
tion to a specific index condition, as 
‘any distinct additional entity that has 
existed or may occur during the clinical 
course of a patient who has the index 
disease under study’ (Maj, 2005). In 
Feinstein’s formulation, the implica-
tion was that a completely different 
and independent disease occurred at 
the same time as another disease. 
These two diseases co-occurred, 
more often than not, randomly.
On the contrary, the Diagnostic and 
Statistical Manual of Mental Disorders 
(DSM) explicitly produces overlapping 
clinical criteria for many diagnoses, 
especially mood and anxiety disorders, 
guaranteeing comorbidity in quite a 
different sense than in the medical 
meaning of the term as co-occurrence 
of independent diseases (Maj, 2005). 
Using DSM definition, it is unclear 
whether concomitant diagnoses actu-
ally reflect the presence of distinct 
clinical entities or refer to multiple 
manifestations of a single clinical entity.
Psychiatric comorbidity is extremely 
common in bipolar disorder (BD). 
More than half of BD patients have an 
additional diagnosis, one of the most dif-
ficult to manage being obsessive–com-
pulsive disorder (OCD) (Amerio et al., 
2014a; Amerio et al., 2014b). In our 
recent meta-analysis, the pooled preva-
lence of OCD in BD was 17.0%, which 
was comparable to the results reported 
by the pooled prevalence of BD in 
OCD (18.35%) (Amerio et al., 2015).
What remains unclear is whether 
this high comorbidity represents the 
frequent occurrence of two inde-
pendent diseases or whether it repre-
sents the occurrence of symptoms of 
one kind in a different disease.
According to Feinstein’s definition, 
‘true’ OCD comorbid with BD would 
represent the random co-occurrence 
of two independent diseases, esti-
mated by multiplication of prevalence 
rates, which are about 1% for each 
condition, producing a very low 
expected true comorbidity of 0.1% in 
the general population.
In agreement with Kraepelin’s 
thought, a psychiatric diagnosis is best 
established by its longitudinal course of 
illness; the evidence so far supports the 
view that the majority of comorbid 
OCD cases appeared to be related to 
mood episodes (Amerio et al., 2014a). 
Therefore, only a substantial minority of 
comorbid BD-OCD may represent 
‘true’ OCD independent of BD with 
obsessive–compulsive (OC) symptoms 
that improve or worsen during mood 
episodes without being related to these.
These results would confirm the 
hypothesis of Mayer-Gross et al. 
reported in a standard 1969 psychiatry 
textbook (Clinical Psychiatry, 1969): 
These people (BD-OCD patients) who, in 
time of health, show no noteworthy 
obsessional traits, but who have phases in 
which compulsive symptoms appear out of 
the blue and rapidly mount up to complete 
incapacitation … Nevertheless these illnesses 
remit and relapse in very much the same way 
as cyclothymic illnesses, may show just as 
much regularity of timing, and are probably to 
be included, from the aetiological point of 
view, in the manic-depressive disorders.
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